Mutations in theembBGene and Their Association with Ethambutol Resistance in Multidrug-ResistantMycobacterium tuberculosisClinical Isolates from Poland
Open Access
- 11 December 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-5
Abstract
Ethambutol (EMB) continues to be used as part of a standard drug regimen for the treatment of tuberculosis (TB). Mutations in the embB gene and those within its conserved EMB resistance determining region (ERDR) in particular have repeatedly been associated with resistance to EMB in Mycobacterium tuberculosis. The aim of this study was to examine the mutational “hot spots” in the embB gene, including the ERDR, among multidrug-resistant (MDR) M. tuberculosis clinical isolates and to find a possible association between embB mutations and resistance to EMB. An 863-bp fragment of the embB gene was sequenced in 17 EMB-resistant and 33 EMB-susceptible MDR-TB isolates. In total, eight embB mutation types were detected in 6 distinct codons of 27 (54%) M. tuberculosis isolates. Mutations in codon 306 were most common, found in both EMB-resistant (9) and EMB-susceptible (11) isolates. Only mutations in codons 406 and 507 were found exclusively in four and one EMB-resistant isolates, respectively. Sequence analysis of the ERDR in the embB gene is not sufficient for rapid detection of EMB resistance, and the codon 306 mutations are not good predictive markers of resistance to EMB.Keywords
This publication has 29 references indexed in Scilit:
- Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of KoreaDiagnostic Microbiology and Infectious Disease, 2013
- Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, ChinaJournal of Antimicrobial Chemotherapy, 2011
- Mycobacterium tuberculosis embB Codon 306 Mutations Confer Moderately Increased Resistance to Ethambutol In Vitro and In VivoAntimicrobial Agents and Chemotherapy, 2011
- Spoligotype-Based Comparative Population Structure Analysis of Multidrug-Resistant and Isoniazid-Monoresistant Mycobacterium tuberculosis Complex Clinical Isolates in PolandJournal of Clinical Microbiology, 2010
- Detection by GenoType MTBDR sl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex IsolatesJournal of Clinical Microbiology, 2010
- Allelic Exchange and Mutant Selection Demonstrate that Common Clinical embCAB Gene Mutations Only Modestly Increase Resistance to Ethambutol in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2010
- Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and RifampinAntimicrobial Agents and Chemotherapy, 2008
- Lack of Correlation betweenembBMutation and Ethambutol MIC inMycobacterium tuberculosisClinical Isolates from ChinaAntimicrobial Agents and Chemotherapy, 2007
- Significance of Mutations in embB Codon 306 for Prediction of Ethambutol Resistance in Clinical Mycobacterium tuberculosis IsolatesAntimicrobial Agents and Chemotherapy, 2006
- Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric MethodsJournal of Clinical Microbiology, 2002